<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02756286</url>
  </required_header>
  <id_info>
    <org_study_id>TNI-NAT-II</org_study_id>
    <secondary_id>R44MH099709</secondary_id>
    <nct_id>NCT02756286</nct_id>
  </id_info>
  <brief_title>Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD</brief_title>
  <acronym>NAT-II</acronym>
  <official_title>Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Think Now Incorporated</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Berkeley</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Oregon Health and Science University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Think Now Incorporated</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to refine a new assessment tool for Attention
      Deficit/Hyperactivity Disorder (ADHD) and then to test its validity (i.e. ability to
      discriminate between individuals with ADHD and healthy controls.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to build upon the success the novel approach and software for
      analyzing electroencephalography (EEG) data to identify biomarkers of ADHD in adults by
      further refining the method. Then to test the ability of this new assessment tool to
      differentiate between adults with ADHD and healthy controls by comparing the classification
      accuracy of the metrics from the new tool to the classification accuracy of existing
      behavioral tests for ADHD.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>NAT Slow Fluctuation Test and Retest to assess change for Test Replicability</measure>
    <time_frame>A single measurement is made for each individual at DAY 1 - the time of the brain wave (EEG) test; and a single measure is made again in each individual at least 30 days later (DAY 2) to identify any differences, to assess replicability of the measure.</time_frame>
    <description>The NAT EEG test simultaneously generates 2 EEG values and 1 behavioral value that are used together as an assessment metric for ADHD. This is a one-time measure to assess its magnitude in ADHD vs Control.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Attention Deficit Hyperactivity Disorder</condition>
  <arm_group>
    <arm_group_label>ADHD: Adults with ADHD</arm_group_label>
    <description>NAT electroencephalography (EEG) test</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls: Healthy adults without ADHD</arm_group_label>
    <description>NAT electroencephalography (EEG) test</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NAT electroencephalography (EEG) test</intervention_name>
    <description>Individuals in both groups are asked to perform standard behavioral tests and an electroencephalography (EEG) test.</description>
    <arm_group_label>ADHD: Adults with ADHD</arm_group_label>
    <arm_group_label>Controls: Healthy adults without ADHD</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with Attention Deficit Hyperactivity Disorder (ADHD) from local clinics, clinicians,
        ADHD community resources in the area of each of the three participating Universities (UCLA,
        UCB, OHSU)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Specific inclusion criteria for ADHD are:

          1. meet established Diagnositic and Statistical Manual-5 criteria for ADHD predominately
             inattentive or combined subtype with clinically significant levels of impairment,
             diagnosed by structured clinical interview, the Mini International Neuropsychiatric
             Interview, and corroborating information

          2. Clinical Global Impression—Severity (CGI-S) score ≥ 4 for ADHD

          3. no lifetime history of DSM-5 bipolar disorder, psychotic disorder, pervasive
             developmental disorder, obsessive-compulsive disorder, substance abuse, or substance
             dependence (except nicotine) as assessed with the Mini International Neuropsychiatric
             Interview (MINI).

          4. able in the opinion of the investigator to complete all required study procedures.

        Exclusion Criteria:

        Exclusion criteria for both groups are:

          1. History of diagnosis of childhood disorder other than ADHD (e.g. autism, dyslexia)

          2. history of any general medical condition likely to require chronic use of medication
             with identified central nervous system (CNS) effects suspected to alter cognitive
             performance

          3. history of seizure disorder, brain tumor, other major neurological disorder or head
             injury resulting in loss of consciousness

          4. serious oxygen deprivation

          5. current psychopathology requiring ongoing treatment with antipsychotic medications,
             mood stabilizers, benzodiazepines, or anticonvulsants

          6. current untreated psychopathology which is rated to be primary in terms of severity
             (greater than ADHD severity)

          7. current treatment with guanfacine.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregory V Simpson, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Think Now, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samantha Betts, B.A.</last_name>
    <phone>310-794-5641</phone>
    <email>UCLA.NATstudy@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of California Berkeley</name>
      <address>
        <city>Berkeley</city>
        <state>California</state>
        <zip>94720</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christine A Zalecki, Ph.D.</last_name>
      <phone>510-642-7142</phone>
      <email>berkeleyNATstudy@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCLA Semel Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Samantha R O'Connell, B.A.</last_name>
      <phone>310-794-5641</phone>
      <email>UCLA.NATstudy@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Agatha Lenartowicz, Ph.D.</last_name>
      <phone>310-794-5641</phone>
      <email>alenarto@ucla.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Mark S Cohen, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Agatha Lenartowicz, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah L Karalunas, Ph.D.</last_name>
      <phone>503-494-5780</phone>
      <email>karaluna@ohsu.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 12, 2015</study_first_submitted>
  <study_first_submitted_qc>April 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>May 12, 2017</last_update_submitted>
  <last_update_submitted_qc>May 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Think Now Incorporated</investigator_affiliation>
    <investigator_full_name>Gregory Simpson, Ph.D.</investigator_full_name>
    <investigator_title>Founder and Chief Scientific Officer</investigator_title>
  </responsible_party>
  <keyword>Electroencephalography</keyword>
  <keyword>Attention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

